Literature DB >> 18637742

Population screening for reproductive risk for single gene disorders in Australia: now and the future.

Martin B Delatycki1.   

Abstract

Abstract As the results of the Human Genome Project are realized, it has become technically possible to identify carriers of numerous autosomal and X-linked recessive disorders. Couples at risk of having a child with one of these conditions have a number of reproductive options to avoid having a child with the condition should they wish. In Australia the haemoglobinopathies are the only group of conditions for which population screening is widely offered and which is government funded. In some Australian states there are also population screening programs for cystic fibrosis and autosomal recessive conditions more common in Ashkenazi Jewish individuals which are generally offered on a user pays basis. It is predicted that as consumer demand increases and testing becomes cheaper, that many people planning or in the early stages of pregnancy will have carrier screening for multiple genetic conditions. This will have significant implications for genetic counseling, laboratory and prenatal testing resources. In addition such screening raises a number of ethical issues including the value of lives of those born with genetic conditions for which screening is available.

Entities:  

Mesh:

Year:  2008        PMID: 18637742     DOI: 10.1375/twin.11.4.422

Source DB:  PubMed          Journal:  Twin Res Hum Genet        ISSN: 1832-4274            Impact factor:   1.587


  12 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

2.  Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making.

Authors:  Alison D Archibald; Belinda J McClaren
Journal:  J Community Genet       Date:  2011-11-17

Review 3.  Carrier screening for beta-thalassaemia: a review of international practice.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

4.  Expanded reproductive carrier screening-how can we do the most good and cause the least harm?

Authors:  Martin B Delatycki; Nigel Laing; Edwin Kirk
Journal:  Eur J Hum Genet       Date:  2019-02-13       Impact factor: 4.246

5.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

6.  ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible.

Authors:  Martin B Delatycki; Michelle Wolthuizen; Veronica Collins; Elizabeth Varley; Joanna Craven; Katrina J Allen; Lyle C Gurrin; Maryanne Aitken; M Kaye Trembath; Lyndal Bond; Gabrielle R Wilson; Sarah E M Stephenson; Ivan Macciocca; Chriselle Hickerton; Paul J Lockhart; Sylvia A Metcalfe
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

7.  "He didn't say that thalassaemia might come up" - β-thalassaemia carriers' experiences and attitudes.

Authors:  Nicole E Cousens; Clara L Gaff; Sylvia A Metcalfe; Martin B Delatycki
Journal:  J Community Genet       Date:  2013-01-13

8.  Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.

Authors:  Sandra Janssens; Davit Chokoshvilli; Carmen Binst; Inge Mahieu; Lidewij Henneman; Anne De Paepe; Pascal Borry
Journal:  Eur J Hum Genet       Date:  2015-07-29       Impact factor: 4.246

9.  High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.

Authors:  Helen Curd; Sharon Lewis; Ivan Macciocca; Margaret Sahhar; Vicki Petrou; Agnes Bankier; Sari Lieberman; Ephrat Levy-Lahad; Martin B Delatycki
Journal:  J Community Genet       Date:  2013-07-27

Review 10.  Tay-Sachs disease: current perspectives from Australia.

Authors:  Raelia M Lew; Leslie Burnett; Anné L Proos; Martin B Delatycki
Journal:  Appl Clin Genet       Date:  2015-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.